Amplatzer PFO Occluder Post-marketing Surveillance Study
NCT: NCT04349995 · COMPLETED
Brief Summary
The purpose of the Amplatzer PFO Occluder post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy information for evaluating the results of the clinical use.
Frequently Asked Questions
What is Amplatzer PFO Occluder Post-marketing Surveillance Study?
Amplatzer PFO Occluder Post-marketing Surveillance Study is a clinical trial registered under NCT04349995. Current status: COMPLETED.
What is the status of NCT04349995?
The current status of NCT04349995 (Amplatzer PFO Occluder Post-marketing Surveillance Study) is: COMPLETED.
When did Amplatzer PFO Occluder Post-marketing Surveillance Study start?
Amplatzer PFO Occluder Post-marketing Surveillance Study started on 2019-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.